Recent Finacing
Recent Raise
Prokarium develops Vaxonella, an engineered oral thermostable Salmonella platform delivering vaccines and microbial immunotherapies via capsules/sachets for enteric fevers, mucosal pathogens, and solid-tumor oncology, with clinical programs ongoing.
